论文信息 - Therapeutics: Click and discover - 字舞流文

Therapeutics: Click and discover

Details of the activity of promising anticancer drugs known as BET inhibitors remain elusive. An approach called click chemistry enables in-depth analysis of how these drugs modulate the function of a crucial target protein, BRD4.

George S Vassiliou | Shankar Balasubramanian | S. Balasubramanian | G. Vassiliou

[1] M. G. Finn,et al. Click Chemistry: Diverse Chemical Function from a Few Good Reactions , 2001 .

[2] Stephen P. Jackson,et al. Small molecule-induced DNA damage identifies alternative DNA structures in human genes , 2012, Nature chemical biology.

[3] Joseph M. Fox,et al. Tetrazine ligation: fast bioconjugation based on inverse-electron-demand Diels-Alder reactivity. , 2008, Journal of the American Chemical Society.

[4] R. M. Owen,et al. An analysis of the attrition of drug candidates from four major pharmaceutical companies , 2015, Nature Reviews Drug Discovery.

[5] S. Robson,et al. Inhibition of BET recruitment to chromatin as an effective treatment for MLL-fusion leukaemia , 2011, Nature.

[6] Mark A. Dawson,et al. BET inhibitor resistance emerges from leukaemia stem cells , 2015, Nature.

[7] R. Rodriguez,et al. Unravelling the genomic targets of small molecules using high-throughput sequencing , 2014, Nature Reviews Genetics.

[8] Steven A Carr,et al. Identifying the proteins to which small-molecule probes and drugs bind in cells , 2009, Proceedings of the National Academy of Sciences.

[9] Anna E Speers,et al. Activity-based protein profiling in vivo using a copper(i)-catalyzed azide-alkyne [3 + 2] cycloaddition. , 2003, Journal of the American Chemical Society.

[10] P. Grandi,et al. Click chemistry enables preclinical evaluation of targeted epigenetic therapies , 2017, Science.